Management Team

GW's senior management team comprises highly experienced pharmaceutical professionals with the necessary skills and expertise to guide new medicines through from early stage research to global clinical development, regulatory approval, commercial manufacture and distribution.

Marilyn Emery - Director of Quality
Plus
Tilden Etges - Director of Pharmacovigilance
Plus
Dr Peter Gibson - Technical Director
Plus
Rupert Haynes- Director of Global Marketing
Plus
Manuel Loureda - Manufacturing Operations Director.
Plus
Alice Mead - Vice President, U.S. Professional Relations
Plus
Professor Roger Pertwee - Director of Pharmacology
Plus
Dr David Potter - Director of Botanical Research and Cultivation
Plus
Richard Potts - Clinical Operations Director
Plus
Dr Philip Robson - Director of the Cannabinoid Research Institute
Plus
Stephen Schultz - Vice President, Investor Relations
Plus
Renuka Soley - Scientific & Partner Liaison Lead
Plus
Dr Kenneth Sommerville - Vice President, Clinical Science
Plus
Colin Stott - Director of Research and Development Operations
Plus
Alison Thompson - Director of Regulatory Affairs
Plus